The abstract is read at the publisher; the summary is JClub's.
A disease-associated microglial subtype with elevated GPNMB expression expands with Alzheimer’s disease pathology in human prefrontal cortex, increasing phagocytic activity.
- Why it matters: Myeloid cells are central to AD biology, but how specific microglial states shift with aging and disease progression remains unclear.
- What they did: The study profiled 832,505 human myeloid cells from 1,607 prefrontal cortex donors, defining six subclasses and 13 transcriptionally distinct microglial subtypes linked to aging and AD progression.
- The result: MITF is required to maintain this microglial state, and neuroprotective effects of the subtype depend on TREM2 in human and mouse models.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.